Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Unaudited financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bandaram Pharma Packtech has informed BSE that its Board of Directors will meet on Thursday, 13 November 2025, at the registered office. The agenda is to consider and approve the Unaudited Standalone and Consolidated financial results along with the Limited Review Report for the quarter and half year ended 30 September 2025. No other specific business has been disclosed, with a routine 'any other matter with chair's permission' clause included. No financial numbers, projections, or commentary are provided in this filing.
This is a routine regulatory intimation and does not contain financial data, so it is unlikely to move the stock on its own. Investors should watch for the actual Q2/H1 FY26 results on or after 13 November 2025 to assess revenue, profitability, and margin trends.